Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway

Metformin, as the first-line oral drug for type 2 diabetes, has proven benefits against aging, cancer and cardiovascular diseases. But the influence of metformin to the immune response and its molecular mechanisms remain obscure. Metformin increases resistance to not only the Gram-negative pathogens...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yi, Liu, Fang, Li, Sanhua, Jiang, Nian, Yu, Changyan, Zhu, Xinting, Qin, Ying, Hui, Jing, Meng, Lingjie, Song, Changwei, Li, Xiao-Fei, Liu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961722/
https://www.ncbi.nlm.nih.gov/pubmed/31851866
http://dx.doi.org/10.1080/21505594.2019.1706305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961722/
https://www.ncbi.nlm.nih.gov/pubmed/31851866
http://dx.doi.org/10.1080/21505594.2019.1706305

Ejemplares similares